← Back to Search

F18 Fluciclovine for Glioblastoma

Q: What related research has been done on this therapeutic approach?

Currently, there are 4 active trials researching this intervention with none of them in the most advanced phase. <a href="https://www.withpower.com/clinical-trials/all">All</a> but one of these tests is located within Salt Lake City while the final test site is elsewhere.

Q: What is the enrollment capacity for this trial?

Unfortunately, this study has since ceased recruitment. The trial was posted on May 30th 2023 and the last update occured on August 25th 2022. For those seeking similar studies, there are currently 1274 clinical trials actively searching for individuals with <a href="https://www.withpower.com/clinical-trials/cancer">cancer</a> as well as 4 other experiments taking part in this treatment protocol that will accept participants.

Q: Has this kind of experiment been conducted previously?

Since 2018, the efficacy of this treatment has been studied extensively. Initially funded by Blue Earth Diagnostics and involving 30 participants, Phase 2 drug approval was eventually granted. At present, 4 live studies are underway in 3 cities across 1 nation.

Q: Is the research team currently enrolling participants for this experiment?

Unfortunately, patient recruitment for this trial has concluded. As of August 25th 2022, it was no longer accepting participants. However, there are still 1274 trials searching for people with malignancies and 4 studies recruiting patients seeking this specific treatment.

Phase < 1

Waitlist Available

Led By Jason Johnson

Research Sponsored by M.D. Anderson Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through study completion, an average of 1 year

Awards & highlights

Study Summary

This trial looks at whether a certain imaging method can help predict how well a treatment will work for brain cancer.

Eligible Conditions

Glioblastoma
Cancer
Brain Tumor

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through study completion, an average of 1 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through study completion, an average of 1 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

To establish the relationship between brain malignancy volume as defined by post-contrast T1 weighted and F18 Fluciclovine before and following LITT.

Trial Design

1Treatment groups

Experimental Treatment

Group I: F18 FluciclovineExperimental Treatment2 Interventions

radioactive imaging agent help researchers better "see" how the disease is responding to laser interstitial thermal therapy (LITT)

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

M.D. Anderson Cancer CenterLead Sponsor

2,966 Previous Clinical Trials

1,804,781 Total Patients Enrolled

42 Trials studying Glioblastoma

1,969 Patients Enrolled for Glioblastoma

Jason JohnsonPrincipal InvestigatorM.D. Anderson Cancer Center

1 Previous Clinical Trials

100 Total Patients Enrolled

Media Library

F18 Fluciclovine Clinical Trial Eligibility Overview. Trial Name: NCT05054400 — Phase < 1

Glioblastoma Research Study Groups: F18 Fluciclovine

Glioblastoma Clinical Trial 2023: F18 Fluciclovine Highlights & Side Effects. Trial Name: NCT05054400 — Phase < 1

F18 Fluciclovine 2023 Treatment Timeline for Medical Study. Trial Name: NCT05054400 — Phase < 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What related research has been done on this therapeutic approach?

"Currently, there are 4 active trials researching this intervention with none of them in the most advanced phase. All but one of these tests is located within Salt Lake City while the final test site is elsewhere."

Answered by AI

What is the enrollment capacity for this trial?

"Unfortunately, this study has since ceased recruitment. The trial was posted on May 30th 2023 and the last update occured on August 25th 2022. For those seeking similar studies, there are currently 1274 clinical trials actively searching for individuals with cancer as well as 4 other experiments taking part in this treatment protocol that will accept participants."

Answered by AI

Has this kind of experiment been conducted previously?

"Since 2018, the efficacy of this treatment has been studied extensively. Initially funded by Blue Earth Diagnostics and involving 30 participants, Phase 2 drug approval was eventually granted. At present, 4 live studies are underway in 3 cities across 1 nation."

Answered by AI

Is the research team currently enrolling participants for this experiment?

"Unfortunately, patient recruitment for this trial has concluded. As of August 25th 2022, it was no longer accepting participants. However, there are still 1274 trials searching for people with malignancies and 4 studies recruiting patients seeking this specific treatment."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Study of Laser Interstitial Thermal Therapy (LITT) Treatment Response Assessment With Fluciclovine PET MR

2020. "Study of Laser Interstitial Thermal Therapy (LITT) Treatment Response Assessment With Fluciclovine PET MR". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05054400.